USPSTF guidelines haven't changed PSA screening practice

This article originally appeared here.
USPSTF Guidelines Haven't Changed PSA Screening Practice
USPSTF Guidelines Haven't Changed PSA Screening Practice

(HealthDay News) -- Despite the 2008 changes in U.S. Preventive Services Task Force (USPSTF) recommendations against prostate-specific antigen (PSA)-based screening for prostate cancer in men 75 years or older, screening rates remained unchanged for men of all ages between 2005 and 2010, according to a research letter published in the April 25 issue of the Journal of the American Medical Association.

Sandip M. Prasad, M.D., M.Phil., of the University of Chicago Medical Center, and colleagues examined demographic, socioeconomic, and functional variables collected from men (aged 40 years or older) free of prostate cancer or other prostate-related conditions. The men participated in the 2005 (5,332 participants) and 2010 (4,640 participants) National Health Interview Survey and had visited a physician in the prior year.

The researchers found that PSA screening rates were unchanged over time in all age groups. PSA screening was unchanged between 2005 and 2010 in men 75 years and older (43.0 and 43.9 percent, respectively). PSA screening was more common in men aged 75 years or older (43.9 percent) than in men aged 40 to 49 years or 50 to 59 in 2010 (12.5 and 33.2 percent, respectively). But men aged 60 to 74 years had the highest screening rate (51.2 percent).

"The discrepancy between the USPSTF recommendation and subsequent practice patterns may reflect lack of guideline awareness, financial incentives, or patient or physician confidence in PSA screening," the authors conclude.

One of the authors disclosed financial ties to pharmaceutical companies.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs